Results 231 to 240 of about 79,768 (305)

Ganglioside biosynthesis. Characterization of uridine diphosphate galactose: GM2 galactosyltransferase in Golgiapparatus from rat liver

, 1976
Francis E. Wilkinson, D. James Morré, T.W. Keenan   +2 more
openalex   +1 more source

Synthesis, function, and therapeutic potential of glycosphingolipids. [PDF]

Front Immunol
Dong L, Cao Z, Han W, Wu Z.
europepmc   +1 more source

A Case of Miller-Fisher Overlap Syndrome With Positive Anti-GM4 Antibody and Atypical Symptoms. [PDF]

Immun Inflamm Dis
Tang M, Tang R, Xu J, Yang Z, Zhang B, Yan Y, Xie J, Long Q, Li Z, Tu E.   +9 more
europepmc   +1 more source

The effect of estrogen deficiency on rat ganglioside metabolism

, 1997
Saatov Ts, E. I. Isaev, M. Zh. Ergashova, O. Yu. Kukina, Agureev An   +4 more
openalex   +1 more source

Profiling glycosphingolipid changes in mouse and human cellular models of lysosomal free sialic acid storage disorder. [PDF]

Mol Genet Metab Rep
Sabir MS, Dobrenis K, Rha AK, Pollard L, Leoyklang P, Marrero M, Ciccone C, Hackbarth ME, Huizing M, Wang RY, Gahl WA, Platt FM, Malicdan MCV.   +12 more
europepmc   +1 more source

Human fibroblasts in culture metabolize differently exogenous G(M3) ganglioside species containing C18 and C20 sphingosine.

, 1998
Vanna Chigorno, M Valsecchi, Sandro Sonnino   +2 more
openalex   +2 more sources

Five-year analysis of efficacy and safety of a bidirectional AAV gene therapy in Tay-Sachs sheep. [PDF]

J Clin Invest
Taghian T, Gallagher J, Bertrand S, Baker WC, Lopez Mercado K, Benatti HR, Hall E, Lopez Y, McElroy A, McCarthy JT, Pulaparthi S, Fernau D, Mather S, Esteves S, Diffie E, Gross A, Lahey HG, Jiang X, Parsley E, Gately R, Prestigiacomo R, Johnson S, Taylor A, Bierfeldt L, Tuominen S, Koehler J, Gao G, Xie J, Su Q, King R, Gounis MJ, Anagnostakou V, Puri A, Batista AR, Sena-Esteves M, Martin DR, Gray-Edwards H.   +36 more
europepmc   +1 more source

Inactivation of staphylococcal, tetanus, and diphtheria toxins by ganglioside.

, 1961
E. A. North, HAZEL M. DOERY
openalex   +1 more source

Targeting GD2 with naxitamab overcomes GD3 synthase-driven immune suppression in triple-negative breast cancer. [PDF]

NPJ Breast Cancer
Anand V, Oderinde B, Siddiqui M, Tyagi A, Borgman J, Wu C, Andreeff M, Battula VL.   +7 more
europepmc   +1 more source

C18:0 GM3 ganglioside's efficacy in LPS-induced parkinsonism: neuroprotection, inflammatory inhibition and gliosis mitigation. [PDF]

Behav Brain Funct
Liu TT, Liu CT, Li IH, Chu YC, Hung HY, Chiu CH, Chou TK, Li SY, Wang TA, Shih JH.   +9 more
europepmc   +1 more source